K23 HL152013/HL/NHLBI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2020	1
2021	7
2022	5
2023	3
2024	4
2025	0

1

Cardiovascular Risk in Patients With Psoriasis: JACC Review Topic of the Week.

Garshick MS, Ward NL, Krueger JG, Berger JS. Garshick MS, et al. J Am Coll Cardiol. 2021 Apr 6;77(13):1670-1680. doi: 10.1016/j.jacc.2021.02.009. J Am Coll Cardiol. 2021. PMID: 33795041 Free PMC article. Review.

2

Lipoprotein(a): Emerging insights and therapeutics.

Kaur G, Abdelrahman K, Berman AN, Biery DW, Shiyovich A, Huck D, Garshick M, Blankstein R, Weber B. Kaur G, et al. Am J Prev Cardiol. 2024 Mar 29;18:100641. doi: 10.1016/j.ajpc.2024.100641. eCollection 2024 Jun. Am J Prev Cardiol. 2024. PMID: 38646022 Free PMC article.

3

Sore, Hot, and at Risk: The Emerging Specialty of Cardio-Rheumatology.

Weber B, Garshick M, Liao KP, Di Carli M. Weber B, et al. J Am Heart Assoc. 2023 Jun 6;12(11):e027846. doi: 10.1161/JAHA.122.027846. Epub 2023 May 26. J Am Heart Assoc. 2023. PMID: 37232258 Free PMC article. No abstract available.

4

Cardiovascular Risk Management in Patients Treated With Janus Kinase Inhibitors.

Shah JT, Shah KT, Femia AN, Lo Sicco KI, Merola JF, Weber B, Garshick MS. Shah JT, et al. J Cardiovasc Pharmacol. 2024 May 1;83(5):392-402. doi: 10.1097/FJC.0000000000001470. J Cardiovasc Pharmacol. 2024. PMID: 37566808 Review.

5

Autoimmune diseases and cardiovascular risk.

Gelfand JM, Wang S, Garshick MS. Gelfand JM, et al. Trends Mol Med. 2022 Dec;28(12):1025-1027. doi: 10.1016/j.molmed.2022.10.007. Epub 2022 Nov 7. Trends Mol Med. 2022. PMID: 36357282

6

Burden of cardiometabolic risk factors and vascular health.

Hamo CE, Schlamp F, Drenkova K, Jindal M, Fadzan M, Akinlonu A, Goldberg I, Garshick MS, Berger JS. Hamo CE, et al. Am Heart J. 2024 Mar;269:201-204. doi: 10.1016/j.ahj.2023.11.004. Epub 2024 Jan 5. Am Heart J. 2024. PMID: 38199832

7

Psoriasis and Cardiovascular Disease-An Ounce of Prevention Is Worth a Pound of Cure.

Garshick MS, Berger JS. Garshick MS, et al. JAMA Dermatol. 2022 Mar 1;158(3):239-241. doi: 10.1001/jamadermatol.2021.4723. JAMA Dermatol. 2022. PMID: 35044422 Free PMC article. No abstract available.

8

Psoriasis and Cardiovascular Disease: Novel Mechanisms and Evolving Therapeutics.

Weber B, Merola JF, Husni ME, Di Carli M, Berger JS, Garshick MS. Weber B, et al. Curr Atheroscler Rep. 2021 Sep 1;23(11):67. doi: 10.1007/s11883-021-00963-y. Curr Atheroscler Rep. 2021. PMID: 34468875 Free PMC article. Review.

9

An inflammatory transcriptomic signature in psoriasis associates with future cardiovascular events.

Garshick MS, Barrett TJ, Cornwell MG, Drenkova K, Garelik J, Weber BN, Schlamp F, Rockman C, Ruggles KV, Reynolds HR, Berger JS. Garshick MS, et al. J Eur Acad Dermatol Venereol. 2023 Jul;37(7):1361-1365. doi: 10.1111/jdv.19049. Epub 2023 Mar 22. J Eur Acad Dermatol Venereol. 2023. PMID: 36924033 Free PMC article.

10

Comparison of comorbidities and adverse events in dermatology and rheumatology patients prescribed tofacitinib: A retrospective analysis.

Needle CD, Klein EJ, Gjonaj J, Nohria A, Karim M, Liu L, Shah J, Betensky RA, Garshick M, Lo Sicco K, Karagounis TK. Needle CD, et al. J Am Acad Dermatol. 2024 Mar;90(3):659-662. doi: 10.1016/j.jaad.2023.11.027. Epub 2023 Nov 24. J Am Acad Dermatol. 2024. PMID: 38008410 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year